2007;11:156–63. 5. Yamashita T, Yoshida T, Ogawa T, Tsuchiya K, Nitta K. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan. Clin Exp Nephrol. 2011;15:831–40.PubMedCrossRef 6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef 7. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;68:228–36.PubMedCrossRef 8. Irie F, Iso H, Sairenchi
T, Fukasawa N, Yamagishi K, Ikehara S, et al. The relationships of proteinuria, serum
creatinine, glomerular filtration rate with cardiovascular disease Selleck LY3039478 mortality in Japanese general Apoptosis inhibitor population. Kidney Int. 2006;69:1264–71.PubMedCrossRef 9. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347–54.PubMedCrossRef 10. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR. Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant. 1997;12:724–8.PubMedCrossRef 11. McMahon LP, Roger SD, Slimheart Investigators Group. Development, prevention, and potential reversal of left ventricular hyperterophy in chronic kidney disease. J Am Soc Nephrol. 2004;15:1640–7.PubMedCrossRef 12. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella
G. Left ventricular hypertrophy in nondiabetic predialysis patients. Am J Kidney Dis. 2005;46:320–7.PubMedCrossRef 13. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative Tideglusib diseases and renal function. Clin Exp Nephrol. 2010;14:558–70.PubMedCrossRef 14. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res. 2008;3:1101–7.CrossRef 15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef 16. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391–8.PubMedCrossRef 17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to GSK126 mouse necropsy findings. Am J Cardiol. 1986;57:450–8.PubMedCrossRef 18. Miura K, Nakagawa H, Ohashi Y, Harada A, Taguri M, Kushiro T, et al. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Circulation.